Tauriga Sciences Inc. Invited to Participate in the Upcoming Kroger "Merchandising Planogram and Sales Planning" Event
March 10 2022 - 11:34AM
InvestorsHub NewsWire
New York, NY -- March 10, 2022 -- InvestorsHub NewsWire --
Tauriga Sciences, Inc. (OTCQB: TAUG)
(“Tauriga” or the “Company”), a New York based diversified Retail
Life Sciences and Pharmaceutical Development Company, today
announced that it has been invited to participate in the
upcoming Kroger “Merchandising Planogram and Sales Planning”
event. This event takes place on March 23, 2022 and is part of
the Kroger Supplier Inclusion Development
Series. Kroger is the United States’ largest
supermarket chain by revenue and the second-largest general
retailer behind Walmart.
The Company is focused on continually building its relationships
with Buyers from large retail companies with national
footprints. The Company believes that once Federal
Cannabis Legislation (“Legalization Bill”) is signed into law, it
can establish a strong and reliable revenue base with mainstream
retailers. The Company is hopeful that such Legislation
will be introduced during the month of April 2022.
In other news, the Company continues to experience strong levels
of growth and demand – with respect to its highest margin
E-Commerce business segment. So far this Quarter, the
Company has received more than 1,150 individual E-Commerce
orders. The Company has now received a total of 9,690
individual E-Commerce orders (“transactions”), since the 2019
launch of that business segment.
E-Commerce Website:
www.taurigum.com
Amazon.com Website:
https://www.amazon.com/s?k=tauri-gum&crid=1WDI6A48F2GK3&sprefix=tauri-gum%2Caps%2C81&ref=nb_sb_noss_1
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG)
is a revenue generating, diversified life sciences company, engaged
in several major business activities and initiatives. The company
manufactures and distributes several proprietary retail products
and product lines, mainly focused on the Cannabidiol (“CBD”) and
Cannabigerol (“CBG”) Edibles market segment. The main product line,
branded as Tauri-Gum™, consists of a proprietary supplement chewing
gum that is Kosher certified, Halal certified, and Vegan Formulated
(CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate),
(CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant),
(DELTA 8 THC Infused Tauri-Gum™ Flavor: Evergreen Mint), (Vitamin C
+ Zinc Infused Tauri-Gum™ Flavor: Pear Bellini), (Caffeine Infused
Tauri-Gum™ Flavor: Cherry Lime Rickey), & (Vitamin D3 Infused
Tauri-Gum™ Flavor: Golden Raspberry). The Company’s
commercialization strategy consists of a broad array of retail
customers, distributors, and a fast-growing E-Commerce business
segment (E-Commerce website: www.taurigum.com). Please visit our
corporate website, for additional information, as well as
inquiries, at http://www.tauriga.com
Complementary to the Company’s retail business, is its ongoing
Pharmaceutical Development initiative. This relates to the
development of a proposed Pharmaceutical grade version of
Tauri-Gum™, for nausea regulation (specifically designed for the
following indication: Patients Subjected to Ongoing Chemotherapy
Treatment). On March 22, 2021, the Company announced that it had
Converted its U.S. Provisional Patent Application (filed on March
17, 2020) into a U.S. Non-Provisional Patent Application. The
Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD
COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”.
On December 18, 2020 the Company disclosed that it had entered into
a Master Services Agreement with CSTI to lead the Company's
clinical development efforts.
The Company is headquartered in Wappingers Falls, New York. In
addition, the Company operates two full time E-Commerce fulfillment
centers: one located in Montgomery, Texas and the other in
Brooklyn, New York.
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements”
as defined by the Private Securities Litigation Reform Act of 1995
which represent management’s beliefs and assumptions concerning
future events. These forward-looking statements are often indicated
by using words such as “may,” “will,” “expects,” “anticipates,”
believes, “hopes,” “believes,” or plans, and may include statements
regarding corporate objectives as well as the attainment of certain
corporate goals and milestones. Forward-looking statements are
based on present circumstances and on management’s present beliefs
with respect to events that have not occurred, that may not occur,
or that may occur with different consequences or timing than those
now assumed or anticipated. Actual results may differ materially
from those expressed in forward looking statements due to known and
unknown risks and uncertainties, such as are not guarantees of
general economic and business conditions, the ability to
successfully develop and market products, consumer and business
consumption habits, the ability to consummate successful
acquisition and licensing transactions, fluctuations in exchange
rates, and other factors over which Tauriga has little or no
control. Many of these risks and uncertainties are discussed in
greater detail in the “Risk Factors” section of Tauriga’s Form 10-K
and other periodic filings made from time to time with the
Securities and Exchange Commission. Such forward-looking statements
are made only as of the date of this release, and Tauriga assumes
no obligation to update forward-looking statements to reflect
subsequent events or circumstances. You should not place undue
reliance on these forward-looking statements.
Contact:
Tauriga Sciences, Inc.
4 Nancy Court, Suite 4
Wappingers Falls, NY 12590
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Company Instagram: @taurigum
Personal Instagram: @sethsms47
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Jul 2023 to Jul 2024